Skip to main content

Insulin Detemir Injection Shortage

Last Updated: June 30, 2024
Status: Current

Products Affected - Description
    • Levemir subcutaneous injection, Novo Nordisk, 100 units/mL, 10 mL vial, 1 count, NDC 00169-3687-12
    • Levemir Flexpen subcutaneous injection, Novo Nordisk, 100 units/mL, 3 mL pen, 5 count, NDC 00169-6432-10
Reason for the Shortage
    • NovoNordisk is transitioning Levemir FlexPens and vials out of the US market by the end of 2024.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • The Levemir FlexPens and vials are expected to be depleted by December 2024.

Updated

Updated June 30, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created November 13, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer